<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04599582</url>
  </required_header>
  <id_info>
    <org_study_id>KÃ¤rrholm: SPCL study</org_study_id>
    <nct_id>NCT04599582</nct_id>
  </id_info>
  <brief_title>Prospective Randomised Study of a New an Uncemented Stem.</brief_title>
  <official_title>Prospective Randomised Study of a New Anteverted Uncemented Stem. Randomised Study Between the SP-CL and the Corail Stem With the Use of a Delta Cup.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sahlgrenska University Hospital, Sweden</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Link America, Inc.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Sahlgrenska University Hospital, Sweden</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Patients will be randomised to either operation with a Corail stem or a SP-CL stem. The&#xD;
      groups are examined with RSA, conventional x-rays, PROM-data and DXA. First evaluation will&#xD;
      be done at two years.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">April 1, 2016</start_date>
  <completion_date type="Actual">May 31, 2019</completion_date>
  <primary_completion_date type="Actual">May 31, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Oxford hip score</measure>
    <time_frame>two years</time_frame>
    <description>Patient reported outcome measure</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>RSA-examination</measure>
    <time_frame>two years</time_frame>
    <description>Migration of stem</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Conventional X-rays</measure>
    <time_frame>two years</time_frame>
    <description>Detection of radiolucent lines</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Harris hip score</measure>
    <time_frame>two years</time_frame>
    <description>Patient reported outcome</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>DXA</measure>
    <time_frame>Two years</time_frame>
    <description>Change of bone mineral density</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">80</enrollment>
  <condition>Hip Osteoarthritis</condition>
  <arm_group>
    <arm_group_label>SP-CL</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Corail</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Hip Arthroplasty</intervention_name>
    <description>Patients are operated with hip replacement.</description>
    <arm_group_label>Corail</arm_group_label>
    <arm_group_label>SP-CL</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Primary osteoartritis Secondary osteoartritis&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Ongoing treatment with corticoid steroids, Active cancer disease, previously known&#xD;
             osteoporosis or osteomalacia, inflammatory arthritis, unsuitable anatomy, difficulties&#xD;
             to speak or understand the Swedish language.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>35 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>October 2020</verification_date>
  <study_first_submitted>October 13, 2020</study_first_submitted>
  <study_first_submitted_qc>October 19, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">October 22, 2020</study_first_posted>
  <last_update_submitted>October 19, 2020</last_update_submitted>
  <last_update_submitted_qc>October 19, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">October 22, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Sahlgrenska University Hospital, Sweden</investigator_affiliation>
    <investigator_full_name>Johan Karrholm</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>hip arthroplasty</keyword>
  <keyword>Joint replacement</keyword>
  <keyword>Uncemented stem</keyword>
  <keyword>Anatomical stem</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoarthritis, Hip</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

